Evidence map›Paper›PMID 36736343›Full record

ArticleZeitschrift fur Gastroenterologie2023

[Strategietreffen: Virushepatitis in Deutschland eliminieren].

T L Tergast, U Protzer, S Zeuzem, L Heitmann, C Sarrazin, M Lehmann, P Ingiliz, M Cornberg, R Zimmermann, M G Gerlich and 3 more

Abstract read
In one paragraph

Article in Zeitschrift fur Gastroenterologie, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. [The status of national and global hepatitis C elimination].Innere Medizin (Heidelberg, Germany) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

T L TergastKlinik für Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625 Hannover.
U ProtzerInstitut für Virologie, Technische Universität München/Helmholtz Zentrum München, München.
S ZeuzemMedizinische Klinik I Gastroenterologie, Hepatologie, Pneumologie, Endokrinologie, Universitätsklinikum Frankfurt, Frankfurt, Deutschland.
L HeitmannMitglied des deutschen Bundestages, Platz der Republik 1, 11011 Berlin.
C SarrazinMedizinische Klinik II, Innere Medizin, St. Josefs-Hospital Wiesbaden, Germany.
M LehmannJustizvollzugskrankenhaus JVA Plötzensee, Saatwinkler Damm 1A, 13627 Berlin, Germany.
P IngilizHôpitaux Universitaires Henri Mondor.
M CornbergKlinik für Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625 Hannover.
R ZimmermannAbteilung für Infektionsepidemiologie, Robert Koch-Institut, Berlin, Germany.
M G GerlichBundeszentrale für gesundheitliche Aufklärung, Köln.
P Buggischifi-Institut für interdisziplinäre Medizin, Hamburg.
B WiebnerDeutsche Leberstiftung, Hannover, Germany.
H WedemeyerKlinik für Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625 Hannover.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36736343
PMCPMC9897951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.